Neither imipramine nor siramesine, two ASMase inhibitors previously reported to block the response to exATP (7, 33), were effective. These results exclude that the MV release mediated by IFN-γ and IL-4 depends on a pathway analogous to that responsible for the exATP-mediated shedding, which is acutely enhanced upon P2X7 activation.